Cargando…
Hepatocellular Carcinoma Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE): Outcome Analysis Using a Model Based On Pre-Treatment CT Texture Features
(1) Introduction and Aim: The aim of this study is to investigate the prognostic value, in terms of response and survival, of CT-based radiomics features for patients with HCC undergoing drug-eluting beads transarterial chemoembolization (DEB-TACE). (2) Materials and Methods: Pre-treatment CT examin...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226518/ https://www.ncbi.nlm.nih.gov/pubmed/34073545 http://dx.doi.org/10.3390/diagnostics11060956 |
_version_ | 1783712305915101184 |
---|---|
author | Tipaldi, Marcello Andrea Ronconi, Edoardo Lucertini, Elena Krokidis, Miltiadis Zerunian, Marta Polidori, Tiziano Begini, Paola Marignani, Massimo Mazzuca, Federica Caruso, Damiano Rossi, Michele Laghi, Andrea |
author_facet | Tipaldi, Marcello Andrea Ronconi, Edoardo Lucertini, Elena Krokidis, Miltiadis Zerunian, Marta Polidori, Tiziano Begini, Paola Marignani, Massimo Mazzuca, Federica Caruso, Damiano Rossi, Michele Laghi, Andrea |
author_sort | Tipaldi, Marcello Andrea |
collection | PubMed |
description | (1) Introduction and Aim: The aim of this study is to investigate the prognostic value, in terms of response and survival, of CT-based radiomics features for patients with HCC undergoing drug-eluting beads transarterial chemoembolization (DEB-TACE). (2) Materials and Methods: Pre-treatment CT examinations of 50 patients with HCC, treated with DEB-TACE were manually segmented to obtain the tumor volumetric region of interest, extracting radiomics features with TexRAD. Response to therapy evaluation was performed basing on post-procedural CT examination compared to pre-procedural CT, using modified RECIST criteria for HCC. The prognostic value of texture analysis was evaluated, investigating the correlation between radiomics features, response to therapy and overall survival. Three models based on texture and clinical variables and a combination of them were finally built; (3) Results: Entropy, skewness, MPP and kurtosis showed a significant correlation with complete response (CR) to TACE (all p < 0.001). A predictive model to identify patients with a high and low probability of CR was evaluated with an ROC curve, with an AUC of 0.733 (p < 0.001). The three models built for survival prediction yielded an HR of 2.19 (95% CI: 2.03–2.35) using texture features, of 1.7 (95% CI: 1.54–1.9) using clinical data and of 4.61 (95% CI: 4.24–5.01) combining both radiomics and clinical data (all p < 0.0001). (4) Conclusion: Texture analysis based on pre-treatment CT examination is associated with response to therapy and survival in patients with HCC undergoing DEB-TACE, especially if combined with clinical data. |
format | Online Article Text |
id | pubmed-8226518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-82265182021-06-26 Hepatocellular Carcinoma Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE): Outcome Analysis Using a Model Based On Pre-Treatment CT Texture Features Tipaldi, Marcello Andrea Ronconi, Edoardo Lucertini, Elena Krokidis, Miltiadis Zerunian, Marta Polidori, Tiziano Begini, Paola Marignani, Massimo Mazzuca, Federica Caruso, Damiano Rossi, Michele Laghi, Andrea Diagnostics (Basel) Article (1) Introduction and Aim: The aim of this study is to investigate the prognostic value, in terms of response and survival, of CT-based radiomics features for patients with HCC undergoing drug-eluting beads transarterial chemoembolization (DEB-TACE). (2) Materials and Methods: Pre-treatment CT examinations of 50 patients with HCC, treated with DEB-TACE were manually segmented to obtain the tumor volumetric region of interest, extracting radiomics features with TexRAD. Response to therapy evaluation was performed basing on post-procedural CT examination compared to pre-procedural CT, using modified RECIST criteria for HCC. The prognostic value of texture analysis was evaluated, investigating the correlation between radiomics features, response to therapy and overall survival. Three models based on texture and clinical variables and a combination of them were finally built; (3) Results: Entropy, skewness, MPP and kurtosis showed a significant correlation with complete response (CR) to TACE (all p < 0.001). A predictive model to identify patients with a high and low probability of CR was evaluated with an ROC curve, with an AUC of 0.733 (p < 0.001). The three models built for survival prediction yielded an HR of 2.19 (95% CI: 2.03–2.35) using texture features, of 1.7 (95% CI: 1.54–1.9) using clinical data and of 4.61 (95% CI: 4.24–5.01) combining both radiomics and clinical data (all p < 0.0001). (4) Conclusion: Texture analysis based on pre-treatment CT examination is associated with response to therapy and survival in patients with HCC undergoing DEB-TACE, especially if combined with clinical data. MDPI 2021-05-26 /pmc/articles/PMC8226518/ /pubmed/34073545 http://dx.doi.org/10.3390/diagnostics11060956 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tipaldi, Marcello Andrea Ronconi, Edoardo Lucertini, Elena Krokidis, Miltiadis Zerunian, Marta Polidori, Tiziano Begini, Paola Marignani, Massimo Mazzuca, Federica Caruso, Damiano Rossi, Michele Laghi, Andrea Hepatocellular Carcinoma Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE): Outcome Analysis Using a Model Based On Pre-Treatment CT Texture Features |
title | Hepatocellular Carcinoma Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE): Outcome Analysis Using a Model Based On Pre-Treatment CT Texture Features |
title_full | Hepatocellular Carcinoma Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE): Outcome Analysis Using a Model Based On Pre-Treatment CT Texture Features |
title_fullStr | Hepatocellular Carcinoma Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE): Outcome Analysis Using a Model Based On Pre-Treatment CT Texture Features |
title_full_unstemmed | Hepatocellular Carcinoma Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE): Outcome Analysis Using a Model Based On Pre-Treatment CT Texture Features |
title_short | Hepatocellular Carcinoma Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE): Outcome Analysis Using a Model Based On Pre-Treatment CT Texture Features |
title_sort | hepatocellular carcinoma drug-eluting bead transarterial chemoembolization (deb-tace): outcome analysis using a model based on pre-treatment ct texture features |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226518/ https://www.ncbi.nlm.nih.gov/pubmed/34073545 http://dx.doi.org/10.3390/diagnostics11060956 |
work_keys_str_mv | AT tipaldimarcelloandrea hepatocellularcarcinomadrugelutingbeadtransarterialchemoembolizationdebtaceoutcomeanalysisusingamodelbasedonpretreatmentcttexturefeatures AT ronconiedoardo hepatocellularcarcinomadrugelutingbeadtransarterialchemoembolizationdebtaceoutcomeanalysisusingamodelbasedonpretreatmentcttexturefeatures AT lucertinielena hepatocellularcarcinomadrugelutingbeadtransarterialchemoembolizationdebtaceoutcomeanalysisusingamodelbasedonpretreatmentcttexturefeatures AT krokidismiltiadis hepatocellularcarcinomadrugelutingbeadtransarterialchemoembolizationdebtaceoutcomeanalysisusingamodelbasedonpretreatmentcttexturefeatures AT zerunianmarta hepatocellularcarcinomadrugelutingbeadtransarterialchemoembolizationdebtaceoutcomeanalysisusingamodelbasedonpretreatmentcttexturefeatures AT polidoritiziano hepatocellularcarcinomadrugelutingbeadtransarterialchemoembolizationdebtaceoutcomeanalysisusingamodelbasedonpretreatmentcttexturefeatures AT beginipaola hepatocellularcarcinomadrugelutingbeadtransarterialchemoembolizationdebtaceoutcomeanalysisusingamodelbasedonpretreatmentcttexturefeatures AT marignanimassimo hepatocellularcarcinomadrugelutingbeadtransarterialchemoembolizationdebtaceoutcomeanalysisusingamodelbasedonpretreatmentcttexturefeatures AT mazzucafederica hepatocellularcarcinomadrugelutingbeadtransarterialchemoembolizationdebtaceoutcomeanalysisusingamodelbasedonpretreatmentcttexturefeatures AT carusodamiano hepatocellularcarcinomadrugelutingbeadtransarterialchemoembolizationdebtaceoutcomeanalysisusingamodelbasedonpretreatmentcttexturefeatures AT rossimichele hepatocellularcarcinomadrugelutingbeadtransarterialchemoembolizationdebtaceoutcomeanalysisusingamodelbasedonpretreatmentcttexturefeatures AT laghiandrea hepatocellularcarcinomadrugelutingbeadtransarterialchemoembolizationdebtaceoutcomeanalysisusingamodelbasedonpretreatmentcttexturefeatures |